MEI Pharma, Inc.'s ticker is and the CUSIP is 552798202. A total of 1 filers reported holding MEI Pharma, Inc. in Q2 2021. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $34,484,000 | +19.4% | 12,494,118 | +23.2% | 5.35% | +12.7% |
| Q2 2021 | $28,893,000 | -16.9% | 10,137,859 | 0.0% | 4.75% | +8.7% |
| Q1 2021 | $34,773,000 | -35.0% | 10,137,859 | -50.0% | 4.37% | -5.5% |
| Q4 2020 | $53,528,000 | +69.2% | 20,275,718 | +100.0% | 4.62% | -39.3% |
| Q3 2020 | $31,630,000 | -24.5% | 10,137,859 | 0.0% | 7.62% | -31.5% |
| Q2 2020 | $41,869,000 | +316.1% | 10,137,859 | +62.2% | 11.13% | +81.1% |
| Q1 2020 | $10,063,000 | -35.1% | 6,250,000 | 0.0% | 6.15% | +11.9% |
| Q4 2019 | $15,500,000 | – | 6,250,000 | – | 5.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 10,137,859 | $28,893,000 | 4.75% |